Yan Leyfman: Discussing Consolidative Transplant After CAR T-Cell Therapy and Outpatient Treatment Optimization
Yan Leyfman/LinkedIn and Alexandra Gomez/vivo.weill.cornell.edu/

Yan Leyfman: Discussing Consolidative Transplant After CAR T-Cell Therapy and Outpatient Treatment Optimization

Yan Leyfman, Medical Correspondent at OncLive, Freelance, Co-Founder and Executive Director of MedNews Week, shared on X:

“Standing room only session at 2026 Lymphoma, Leukemia and Myeloma Congress for Dr Alexandra Gomez discussing the consolidative transplant post CAR T-cell therapy and how to optimize CAR T-cells in the outpatient setting.”

Yan Leyfman

Other articles about CAR T-cell therapy on OncoDaily.